Skip to content

Study · In vitro (cell-free) · 2016

1 result

Characterization of 12 GnRH peptide agonists - a kinetic perspective.

Nederpelt I, Georgi V, Schiele F, Nowak-Reppel K, Fernández-Montalván AE, IJzerman AP, Heitman LH

British journal of pharmacology4 Nov 2015Cited by 28 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

1 result from studies that gave the peptide. No result from this study comes from people.

  1. 01LabIn vitro (cell-free)Activity measurement

    In lab tests at the human GnRH receptor, goserelin had a residence time of 5.6 min.

    In plain wordsIn lab tests, goserelin remained bound to the human GnRH receptor for a residence time of 5.6 minutes.

    Peptide
    Goserelin
    Outcome
    Not applicableGnRH receptor residence time
    Study

    humann: not reported in source

    Human GnRH receptor binding assays
    Outcome group
    Receptor activity and mechanism · Pharmacology
    Studied dose
    Dose not stated

    Measurements

    Residence time
    5.6 min
    goserelin

    Source sentences

    Summary
    Interestingly, the binding kinetics of the peptide agonists were more divergent than their affinities with residence times ranging from 5.6 min (goserelin) to 125 min (deslorelin).
    1 context sentence
    Summary · context
    A novel radioligand-binding competition association assay was developed and optimized for the human GnRH receptor with the use of a radiolabelled peptide agonist, [(125) I]-triptorelin.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    28 Oct 2026, 02:03 UTC

    Study results updated

  2. Version 1

    27 Oct 2026, 16:35 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.